+43 316 269 205 office@innophore.com

Take a look at this release from Doru Roiban’s group where they outline GSK’s perspective on the current status of biocatalysis for pharmaceutical manufacturing.

biocatalysis Enzymes

 

“This need for speed applies both to initial identification of a potential industrialisable biocatalyst and its subsequent development and scale up.”

Our next generation enzyme discovery can support you to achieve a faster time-to-market!


Innophore GmbH